Results 191 to 200 of about 44,601,277 (361)

TRPM4 contributes to cell death in prostate cancer tumor spheroids, and to extravasation and metastasis in a zebrafish xenograft model system

Molecular Oncology, EarlyView.
Transient receptor potential melastatin‐4 (TRPM4) is overexpressed in prostate cancer (PCa). Knockout of TRPM4 resulted in reduced PCa tumor spheroid size and decreased PCa tumor spheroid outgrowth. In addition, lack of TRPM4 increased cell death in PCa tumor spheroids.
Florian Bochen, Saurav Subedi, Federico La Manna, Sofia Jarrin, Irida Papapostolou, Marianna Kruithof‐de Julio, Christine Peinelt   +6 more
wiley   +1 more source

The financial impact of COVID-19: Evidence from an event study of global hospitality firms. [PDF]

Res Int Bus Finance, 2021
Clark J, Mauck N, Pruitt SW.
europepmc   +1 more source

The thread of space, time and event: An implication in media studies

, 1970
Krishna Prasad Poudel
openalex   +2 more sources

A study of the electron image due to ionizing events in a two-dimensional liquid argon TPC with a 24 cm drift gap [PDF]

, 1990
S. Bonetti, A. Braggiotti, E. Buckley, Mauro Campanella, G. Carugno, G. Cecchet, P. Cennini, S. Centro, A. Ciocio, Sergio Cittolin, B. Dainese, M. Ferro-Luzzi, F. Gasparini, A. Gonidec, P.F. Manfredi, Emanuela Meroni, Raúl C. Muñoz, J.M. Perreau, F. Pietropaolo, F. Ptohos, F. Ragusa, P. Rossi, C. Rubbia, D. Schinzel, Walter Schmidt, W. Seidl   +25 more
openalex   +1 more source

Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancer

Molecular Oncology, EarlyView.
Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti, Shingo Inagaki, Tuyen Thuy Bich Ho, Akihiro Seki, Keiko Yoshida, Kosuke Satomura, Yoshio Sakai, Shuichi Kaneko, Taro Yamashita   +8 more
wiley   +1 more source

Real Estate Divestitures and Stock Price Performance Using Alternative Event Study Variance Estimators

, 1970
Thomas H. Strickland, Edward Hughes, Chen‐Chin Chu, Donald H. Wort   +3 more
openalex   +2 more sources

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

Molecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia, Anouk C. de Jong, Lisanne F. van Dessel, Vanja de Weerd, Corine Beaufort, Jean Helmijr, José Alberto Nakauma‐González, Job van Riet, Paul Hamberg, Daniel Vis, Michiel S. van der Heijden, Nick Beije, Martijn P. Lolkema, Teoman Deger, Saskia M. Wilting, Ronald de Wit, Maurice P. H. M. Jansen, John W. M. Martens   +17 more
wiley   +1 more source

A STUDY ON THE PROBABILISTIC CHARACTERISTICS OF THE GENERATIONS IN HYDROLOGIC EVENTS

, 1972
Nobutada Takase, Hidetoshi Suzuki
openalex   +2 more sources

Integration of single‐cell and bulk RNA‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer

Molecular Oncology, EarlyView.
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley   +1 more source